Global Influenza Diagnostic Market Report 2024

Influenza Diagnostic Global Market Report 2024 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Influenza Diagnostic Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Influenza Diagnostic Market Definition And Segments

Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

The main traditional diagnostic test types of influenza diagnostics are rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays and others. Rapid influenza diagnostic tests (RIDTs) are immunoassays that can detect the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and provide a qualitative result (positive vs. negative). The various molecular diagnostic tests include Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, other isothermal nucleic acid amplification tests and are used by hospitals and clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users.

The influenza diagnostic market covered in this report is segmented –

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.59 billion in 2023 to $2.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to public health concerns, technological advancements, antiviral medications, pandemic preparedness.

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to continuing seasonal influenza, point-of-care testing, remote and home testing, digital health integration. Major trends in the forecast period include point-of-care testing, molecular diagnostics, antigen-based tests, multiplex assays, automation and robotics.

Rapid Diagnostic Tests Revolutionize Influenza Diagnosis, Fueling Market Growth

Rapid diagnostic tests are expected to propel the growth of the influenza diagnostic market going forward. Diagnostic tests are medical procedures or tools used to confirm or rule out a condition or disease. Rapid influenza diagnostic tests (RIDTs) can detect influenza viral antigens in 10-15 minutes with moderate sensitivity (50-70%). For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, during September 2020 to May 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for an influenza virus. Thus, rapid diagnostic tests are driving the growth of the influenza diagnostic market.

Increasing Funding For Diagnostics Accelerates Scientific Progress

The major factor driving the market is increasing funding for research on influenza diagnostics. Addressing the public health impact of influenza disease requires a proper understanding of the virus and its effect on individuals and populations. Therefore, it is important to accelerate the pace of scientific research progress that can have the greatest public health impact. Many public and private health organizations, researchers, health professionals, biopharmaceutical companies have maximized the spending for research funds or grants to reduce the risk of the emergence of pandemic influenza. For instance, in April 2021, the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, funded $24 million to help five Centers of Excellence for Influenza Research and Response (CEIRR), including the one at St. Jude Children's Research Hospital. More than $8.9 million of the first year's funding for St. Jude's research provided by the federal contract was to understand better, forecast, track, and treat developing influenza and other viruses.

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, Altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., LabCorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Variability In Sensitivity And Specificity Hampers Influenza Diagnostic Market Growth

The variability in sensitivity and specificity among the influenza diagnostic tests is restraining the growth of the market. In most rapid flu tests, there are difficulties in identifying patients with influenza. The sensitivity of rapid flu tests ranges from 10-80% across various patient populations. Most diagnostic tests show an increase in the rate of false-negative results during low influenza virus activity, which often leads to an incorrect diagnosis. Thus, the variability in sensitivity and specificity is restraining the growth of the influenza diagnostic market.

A Breakthrough In Simultaneous Influenza And COVID-19 Detection

Major companies operating in the influenza diagnostic market are developing innovative products such as Lucira COVID-19 & Flu Home Test for the simultaneous rapid qualitative detection. The Lucira COVID-19 and Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes. For instance, in February 2023, Pfizer Inc., a US-based pharmaceutical industry company received approval for the Lucira by Pfizer COVID-19 & Flu Home Test. The test can detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19.

The Growing Popularity Of Rapid Influenza Diagnostic Tests (RIDTS) In Influenza Diagnosis

Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

Thermo Fisher Strengthens Diagnostic Capabilities With Acquisition Of Mesa Biotech

In February 2021, Thermo Fisher Scientific Inc., a US-based company specializing in clinical development, acquired Mesa Biotech, Inc. for an undisclosed amount. Through this acquisition, Thermo Fisher will increase manufacturing volume, achieve cost efficiencies, and deliver much-needed diagnostics to market faster and at a larger scale. Mesa Biotech, Inc. is a US-based infectious disease diagnostic company.

North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the influenza diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides influenza diagnostic market statistics, including influenza diagnostic industry global market size, regional shares, competitors with a influenza diagnostic market share, detailed influenza diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. This influenza diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Influenza Diagnostic Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.79 billion
Revenue Forecast In 2033 $3.68 billion
Growth Rate CAGR of 7.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled F. Hoffmann-La Roche Ltd.; Quidel Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Hologic Inc.; Becton Dickinson and Company; DiaSorin SpA; Luminex Corporation; Meridian Bioscience Inc.; GenMark Diagnostics Inc.; SA Scientific Ltd.; Sekisui Diagnostics LLC; bioMérieux Inc.; Danaher Corporation; Siemens Healthineers AG; Coris Bioconcept Sprl; Mast Group; Elitech Technology lnc.; Analytik Jena AG; altona Diagnostics GmbH; Tecan Trading AG; Genome Diagnostics Pvt Ltd.; Germaine Laboratories Inc.; Response Biomedical Corporation; TAUNS Laboratories Inc.; TRUPCR Europe Ltd.; Quest Diagnostics Inc.; Labcorp Employer Services Inc.; TotalWellness Ltd.; Health Advocate Inc.; Optum Global Solutions Private Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Influenza Diagnostic Market Characteristics

    3. Influenza Diagnostic Market Trends And Strategies

    4. Influenza Diagnostic Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Influenza Diagnostic Market Size and Growth

    5.1. Global Influenza Diagnostic Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Influenza Diagnostic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Influenza Diagnostic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Influenza Diagnostic Market Segmentation

    6.1. Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Rapid Influenza Diagnostic Tests (RIDT)

    Viral Culture

    DFA

    Serological Assays

    Other Traditional Diagnostic Tests

    6.2. Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    Isothermal Nucleic Acid Amplification Tests (INAAT)

    Loop Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Other Isothermal Nucleic Acid Amplification Tests

    Other Molecular Diagnostic Tests

    6.3. Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Clinical Laboratories

    Diagnostic Reference Laboratories

    Academic/Research Institutes

    Other End Users

    7. Influenza Diagnostic Market Regional And Country Analysis

    7.1. Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Influenza Diagnostic Market

    8.1. Asia-Pacific Influenza Diagnostic Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Influenza Diagnostic Market

    9.1. China Influenza Diagnostic Market Overview

    9.2. China Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Influenza Diagnostic Market

    10.1. India Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Influenza Diagnostic Market

    11.1. Japan Influenza Diagnostic Market Overview

    11.2. Japan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Influenza Diagnostic Market

    12.1. Australia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Influenza Diagnostic Market

    13.1. Indonesia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Influenza Diagnostic Market

    14.1. South Korea Influenza Diagnostic Market Overview

    14.2. South Korea Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Influenza Diagnostic Market

    15.1. Western Europe Influenza Diagnostic Market Overview

    15.2. Western Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Influenza Diagnostic Market

    16.1. UK Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Influenza Diagnostic Market

    17.1. Germany Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Influenza Diagnostic Market

    18.5. France Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Influenza Diagnostic Market

    19.9. Italy Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Influenza Diagnostic Market

    20.13. Spain Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Influenza Diagnostic Market

    21.1. Eastern Europe Influenza Diagnostic Market Overview

    21.2. Eastern Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Influenza Diagnostic Market

    22.1. Russia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Influenza Diagnostic Market

    23.1. North America Influenza Diagnostic Market Overview

    23.2. North America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Influenza Diagnostic Market

    24.1. USA Influenza Diagnostic Market Overview

    24.2. USA Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Influenza Diagnostic Market

    25.1. Canada Influenza Diagnostic Market Overview

    25.2. Canada Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Influenza Diagnostic Market

    26.1. South America Influenza Diagnostic Market Overview

    26.2. South America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Influenza Diagnostic Market

    27.1. Brazil Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Influenza Diagnostic Market

    28.1. Middle East Influenza Diagnostic Market Overview

    28.2. Middle East Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Influenza Diagnostic Market

    29.1. Africa Influenza Diagnostic Market Overview

    29.2. Africa Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Influenza Diagnostic Market Competitive Landscape And Company Profiles

    30.1. Influenza Diagnostic Market Competitive Landscape

    30.2. Influenza Diagnostic Market Company Profiles

    30.2.1. F. Hoffmann-La Roche Ltd.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Quidel Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Thermo Fisher Scientific Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Abbott Laboratories

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Hologic Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Influenza Diagnostic Market Competitive Benchmarking

    32. Global Influenza Diagnostic Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Influenza Diagnostic Market

    34. Influenza Diagnostic Market Future Outlook and Potential Analysis

    34.1 Influenza Diagnostic Market In 2028 - Countries Offering Most New Opportunities

    34.2 Influenza Diagnostic Market In 2028 - Segments Offering Most New Opportunities

    34.3 Influenza Diagnostic Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 75: Quidel Corporation Financial Performance
  • Table 76: Thermo Fisher Scientific Inc. Financial Performance
  • Table 77: Abbott Laboratories Financial Performance
  • Table 78: Hologic Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 75: Quidel Corporation Financial Performance
  • Figure 76: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 77: Abbott Laboratories Financial Performance
  • Figure 78: Hologic Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the influenza diagnostic market?

Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection. For further insights on the influenza diagnostic market, request a sample here

How will the influenza diagnostic market drivers and restraints affect the influenza diagnostic market dynamics? What forces will shape the influenza diagnostic industry going forward?

The influenza diagnostic market major growth driver - rapid diagnostic tests revolutionize influenza diagnosis, fueling market growth. For further insights on the influenza diagnostic market, request a sample here

What is the forecast market size or the forecast market value of the influenza diagnostic market ?

The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.59 billion in 2023 to $2.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to public health concerns, technological advancements, antiviral medications, pandemic preparedness. The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to continuing seasonal influenza, point-of-care testing, remote and home testing, digital health integration. Major trends in the forecast period include point-of-care testing, molecular diagnostics, antigen-based tests, multiplex assays, automation and robotics. For further insights on the influenza diagnostic market, request a sample here

How is the influenza diagnostic market segmented?

The influenza diagnostic market is segmented
1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users For further insights on the influenza diagnostic market,
request a sample here

Which region has the largest share of the influenza diagnostic market? What are the other regions covered in the report?

North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the influenza diagnostic market, request a sample here.

Who are the major players in the influenza diagnostic market?

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd. For further insights on the influenza diagnostic market, request a sample here.

What are the key trends in the influenza diagnostic market?

Major trend in the influenza diagnostic market - a breakthrough in simultaneous influenza and covid-19 detection. For further insights on the influenza diagnostic market, request a sample here.

What are the major opportunities in the influenza diagnostic market? What are the strategies for the influenza diagnostic market?

For detailed insights on the major opportunities and strategies in the influenza diagnostic market, request a sample here.

How does the influenza diagnostic market relate to the overall economy and other similar markets?

For detailed insights on influenza diagnostic market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the influenza diagnostic industry?

For detailed insights on the mergers and acquisitions in the influenza diagnostic industry, request a sample here.

What are the key dynamics influencing the influenza diagnostic market growth? SWOT analysis of the influenza diagnostic market.

For detailed insights on the key dynamics influencing the influenza diagnostic market growth and SWOT analysis of the influenza diagnostic industry, request a sample here.